Therefore, we assessed the relative mRNA expression level of HYAL2 in four glioma cell lines (U251, LN229, U87, A172) and HUVECs, which showed that the expression of HYAL2 in glioma cell lines was increased significantly compared with that in HUVECs (Fig. 2A). The gene discussed is HYAL2; the disease is central nervous system cancer.